Authors
Joong‐Won Park, Minshan Chen, Massimo Colombo, Lewis R Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip Johnson, Samuel Wagner, Lucinda S Orsini, Morris Sherman
Publication date
2015/9
Journal
Liver International
Volume
35
Issue
9
Pages
2155-2166
Description
Background & Aims
Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. The global HCC BRIDGE study was a multiregional, large‐scale, longitudinal cohort study undertaken to improve understanding of real‐life management of patients with HCC, from diagnosis to death.
Methods
Data were collected retrospectively from January 2005 to September 2012 by chart reviews of eligible patients newly diagnosed with HCC at participating institutions.
Results
Forty‐two sites in 14 countries contributed final data for 18 031 patients. Asia accounted for 67% of patients, Europe for 20% and North America for 13%. As expected, the most common risk factor was hepatitis C virus in North America, Europe and Japan, and hepatitis B virus in China, South Korea and Taiwan. The most common Barcelona Clinic Liver Cancer stage at diagnosis was C in North America, Europe, China …
Scholar articles
JW Park, M Chen, M Colombo, LR Roberts, M Schwartz… - Liver International, 2015